These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 8731307)
1. [The role of low-molecular-weight heparin in unstable angina, acute myocardial infarction and post-elective percutaneous transluminal coronary angioplasty]. Pimentel Filho WA Arq Bras Cardiol; 1995 Dec; 65(6):517-8. PubMed ID: 8731307 [No Abstract] [Full Text] [Related]
2. [The role of low-molecular-weight heparin in unstable angina, acute myocardial infarction and post-elective percutaneous transluminal coronary angioplasty]. Cláudio Correia LC; Neubauer C; Azevedo A; Ribeiro F; Braga J; Carlos Passos L; Teixeira M; Matos M; Aires V; Souza V Arq Bras Cardiol; 1995 Dec; 65(6):475-8. PubMed ID: 8731298 [TBL] [Abstract][Full Text] [Related]
3. Low-molecular-weight heparin versus unfractionated heparin for unstable coronary disease. Krulewitz A N Engl J Med; 1998 Jan; 338(2):130; author reply 131. PubMed ID: 9424584 [No Abstract] [Full Text] [Related]
4. Low-molecular-weight heparin versus unfractionated heparin for unstable coronary disease. Goodall AH; Knight C N Engl J Med; 1998 Jan; 338(2):130-1. PubMed ID: 9424585 [No Abstract] [Full Text] [Related]
5. Low molecular weight heparins for acute coronary syndrome: tackling the issues head-on. Antman EM Am Heart J; 2003 Aug; 146(2):191-3. PubMed ID: 12891179 [No Abstract] [Full Text] [Related]
6. Low-molecular-weight heparins for the treatment of acute coronary syndromes. Wong GC; Giugliano RP Semin Vasc Med; 2003 Nov; 3(4):391-402. PubMed ID: 15199446 [TBL] [Abstract][Full Text] [Related]
7. Use of low-molecular-weight heparin and glycoprotein IIb/IIIa inhibitors in acute coronary syndromes. Fernandez JS; Sadaniantz A Med Health R I; 2001 Feb; 84(2):37-43. PubMed ID: 11272658 [No Abstract] [Full Text] [Related]
8. The present and future of heparin, low molecular weight heparins, pentasaccharide, and hirudin for venous thromboembolism and acute coronary syndromes. Haas S Semin Vasc Med; 2003 May; 3(2):139-46. PubMed ID: 15199477 [TBL] [Abstract][Full Text] [Related]
15. Antithrombotic therapy and the transition to the catheterization laboratory in UA/NSTEMI. Ferguson JJ; Wilson JM; Diez J Minerva Cardioangiol; 2007 Oct; 55(5):529-56. PubMed ID: 17912162 [TBL] [Abstract][Full Text] [Related]
19. [The importance of thrombin and its inhibition in unstable angina. Nonfractionated heparin, hirudin and defractionated heparins]. López-Sendón J; López de Sá E; Rubio Sanz R; Delcán Domínguez JL Rev Esp Cardiol; 1999; 52 Suppl 1():76-89. PubMed ID: 10364817 [TBL] [Abstract][Full Text] [Related]
20. Development and evaluation committees' methods for appraising new drugs. Committee failed to meet aims in producing report on low molecular weight heparins. Bosanquet N; Fox K BMJ; 2000 Mar; 320(7236):714-5. PubMed ID: 10710594 [No Abstract] [Full Text] [Related] [Next] [New Search]